Martin, R.C.G., II; White, R.R.; Bilimoria, M.M.; Kluger, M.D.; Iannitti, D.A.; Polanco, P.M.; Hammil, C.W.; Cleary, S.P.; Heithaus, R.E.; Welling, T.;
et al. Effectiveness and Safety of Irreversible Electroporation When Used for the Ablation of Stage 3 Pancreatic Adenocarcinoma: Initial Results from the DIRECT Registry Study. Cancers 2024, 16, 3894.
https://doi.org/10.3390/cancers16233894
AMA Style
Martin RCG II, White RR, Bilimoria MM, Kluger MD, Iannitti DA, Polanco PM, Hammil CW, Cleary SP, Heithaus RE, Welling T,
et al. Effectiveness and Safety of Irreversible Electroporation When Used for the Ablation of Stage 3 Pancreatic Adenocarcinoma: Initial Results from the DIRECT Registry Study. Cancers. 2024; 16(23):3894.
https://doi.org/10.3390/cancers16233894
Chicago/Turabian Style
Martin, Robert C. G., II, Rebekah Ruth White, Malcolm M. Bilimoria, Michael D. Kluger, David A. Iannitti, Patricio M. Polanco, Chet W. Hammil, Sean P. Cleary, Robert Evans Heithaus, Theodore Welling,
and et al. 2024. "Effectiveness and Safety of Irreversible Electroporation When Used for the Ablation of Stage 3 Pancreatic Adenocarcinoma: Initial Results from the DIRECT Registry Study" Cancers 16, no. 23: 3894.
https://doi.org/10.3390/cancers16233894
APA Style
Martin, R. C. G., II, White, R. R., Bilimoria, M. M., Kluger, M. D., Iannitti, D. A., Polanco, P. M., Hammil, C. W., Cleary, S. P., Heithaus, R. E., Welling, T., & Chan, C. H. F.
(2024). Effectiveness and Safety of Irreversible Electroporation When Used for the Ablation of Stage 3 Pancreatic Adenocarcinoma: Initial Results from the DIRECT Registry Study. Cancers, 16(23), 3894.
https://doi.org/10.3390/cancers16233894
